ProCE Banner Activity


Integrating New Data From CROI 2024: Pharmacist Perspectives


Hear expert insights on the most clinically relevant data presented at CROI 2024, as well as other key studies significant to the advancement of HIV patient care.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: April 10, 2024

Expiration: April 09, 2025



Nimish Patel

Nimish Patel, PharmD, PhD, AAHIVP

Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

Samantha Strong

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES

Clinical Director of Pharmacy
Nevada Health Centers
Las Vegas, Nevada

Provided by

Provided by Clinical Care Options, LLC, in partnership with the American Academy of HIV Medicine

ProCE Banner


Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare



ProCE Banner

Target Audience

This program is intended for pharmacists and other healthcare professionals who provide care for people living with or at risk of HIV infection. 

Program Learning Goal

The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary antiretroviral regimens. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Nimish Patel, PharmD, PhD, AAHIVP

Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

Nimish Patel, PharmD, PhD, AAHIVP: researcher: Gilead.

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES

Clinical Director of Pharmacy
Nevada Health Centers
Las Vegas, Nevada

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES: consultant/advisor/speaker: Gilead, ViiV.

The planners and content peer reviewers from Clinical Care Options, LLC and AAHIVM do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 10, 2024, through April 09, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC, and the American Academy of HIV Medicine. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-24-103-H02-P

Type of Activity: Application

Upon successfully completing the post-test with a score of 65 and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.